Durable Disease Control with Local Treatment for Oligoprogression of Metastatic Solid Tumors Treated with Immune Checkpoint Blockade

被引：0
|
作者：
Sindhu, K. [1 ]
Leiter, A. [2 ]
Carroll, E. [3 ]
Brooks, D. [3 ]
Ben Shimol, J. [4 ]
Eisenberg, E. [3 ]
Gallagher, E. J. [2 ,5 ]
Stock, R. G. [1 ]
Galsky, M. [5 ,6 ]
Buckstein, M. [1 ]
机构：
[1] Icahn Sch Med Mt Sinai, Dept Radiat Oncol, New York, NY 10029 USA
[2] Icahn Sch Med Mt Sinai, Dept Med, Div Endocrinol, New York, NY 10029 USA
[3] Icahn Sch Med Mt Sinai, Dept Med, New York, NY 10029 USA
[4] Icahn Sch Med Mt Sinai, Dept Med, Div Rheumatol, New York, NY 10029 USA
[5] Icahn Sch Med Mt Sinai, Tisch Canc Inst, New York, NY 10029 USA
[6] Icahn Sch Med Mt Sinai, Dept Med, Div Hematol & Med Oncol, New York, NY 10029 USA
来源：
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2019年 / 105卷 / 01期
关键词：
D O I：
10.1016/j.ijrobp.2019.06.1028
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
3511
引用
收藏
页码：E650 / E650
页数：1
相关论文
共 50 条
  • [41] Neurologic immune related adverse events (irAEs) in patients with metastatic solid tumors treated with immune checkpoint inhibitors: a single institution retrospective analysis
    Malani, Rachna
    Haggiagi, Aya
    Holder, Jenessa
    Shames, Yelena
    Briggs, Samuel
    Callahan, Margaret
    Santomasso, Bianca
    NEUROLOGY, 2018, 90
  • [42] Immune-related dissociated response as a specific atypical response pattern in solid tumors with immune checkpoint blockade
    Guan, Yaping
    Feng, Dongfeng
    Yin, Beibei
    Li, Kun
    Wang, Jun
    THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2022, 14
  • [43] Hyperthermia combined with immune checkpoint inhibitor therapy in the treatment of primary and metastatic tumors
    Yang, Ximing
    Gao, Miaozhi
    Xu, Runshi
    Tao, Yangyang
    Luo, Wang
    Wang, Binya
    Zhong, Wenliang
    He, Lan
    He, Yingchun
    FRONTIERS IN IMMUNOLOGY, 2022, 13
  • [44] Prevalence of PDL1 Amplification and Preliminary Response to Immune Checkpoint Blockade in Solid Tumors
    Goodman, Aaron M.
    Piccioni, David
    Kato, Shumei
    Boichard, Amelie
    Wang, Huan-You
    Frampton, Garrett
    Lippman, Scott M.
    Connelly, Caitlin
    Fabrizio, David
    Miller, Vincent
    Sicklick, Jason K.
    Kurzrock, Razelle
    JAMA ONCOLOGY, 2018, 4 (09) : 1237 - 1244
  • [45] Dual Immune Checkpoint Blockade and Hypofractionated Radiation in Recurrent/Metastatic Squamous Cell Carcinomas of the Head and Neck Previously Treated with Immune Checkpoint Inhibitors
    Rodriguez, C. P.
    Fromm, J.
    Liao, J. J.
    Laramore, G. E.
    Lo, S. S.
    Goff, P. H.
    Santana-Davila, R.
    Martins, R. G.
    Futran, N.
    Houlton, J.
    Barber, B.
    Parvathaneni, U.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2022, 114 (03): : E282 - E283
  • [46] In solid tumors, neoadjuvant or adjuvant immune checkpoint blockade increases treatment-related grade 3 or 4 adverse events
    Bertolaccini, Luca
    ANNALS OF INTERNAL MEDICINE, 2024, 177 (04) : JC42 - JC42
  • [47] THE DEVELOPMENT OF NEUROLOGIC IMMUNE RELATED ADVERSE EVENTS (irAEs) IN PATIENTS WITH METASTATIC SOLID TUMORS TREATED WITH IMMUNE CHECKPOINT INHIBITORS: A SINGLE INSTITUTION RETROSPECTIVE ANALYSIS
    Malani, Rachna
    Haggiagi, Aya
    Holder, Jenessa
    Shames, Yelena
    Briggs, Samuel
    Santomasso, Bianca
    Callahan, Margaret
    NEURO-ONCOLOGY, 2017, 19 : 168 - 168
  • [48] Local treatment on the outcome of immune-checkpoint inhibitors in metastatic urothelial carcinoma
    Maldonado, J.
    Morales Barrera, R.
    Vidal, N.
    Feltes, N.
    Domenech, M.
    Puente, J.
    Figols, M.
    Gonzalez, M.
    Lozano, F.
    Lopez, H.
    Gallardo, E.
    Moreno, D.
    Suarez, C.
    Morote, J.
    Carles, J.
    Giralt, J.
    RADIOTHERAPY AND ONCOLOGY, 2020, 152 : S637 - S638
  • [49] Applicability of the lung immune prognostic index (LIPI) in patients with metastatic solid tumors when treated with immune checkpoint inhibitors (ICI) in early clinical trials
    Varga, A.
    Bernard-Tessier, A.
    Auclin, E.
    Perez, L. Mezquita
    Baldini, C.
    Planchard, D.
    Marabelle, A.
    Hollebecque, A.
    Besse, B.
    Massard, C.
    ANNALS OF ONCOLOGY, 2019, 30
  • [50] A Retrospective Analysis of a Cohort of Patients Treated With Immune Checkpoint Blockade in Recurrent/Metastatic Head and Neck Cancer
    Bila, Michel
    Van Dessel, Jeroen
    Smeets, Maximiliaan
    Vander Poorten, Vincent
    Nuyts, Sandra
    Meulemans, Jeroen
    Clement, Paul M.
    FRONTIERS IN ONCOLOGY, 2022, 12
12345